首页> 外文期刊>British journal of ophthalmology >Costs and consequences of automated algorithms versus manual grading for the detection of referable diabetic retinopathy.
【24h】

Costs and consequences of automated algorithms versus manual grading for the detection of referable diabetic retinopathy.

机译:自动算法与人工分级的成本和后果,以检测可参考的糖尿病性视网膜病。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

AIMS: To assess the cost-effectiveness of an improved automated grading algorithm for diabetic retinopathy against a previously described algorithm, and in comparison with manual grading. METHODS: Efficacy of the alternative algorithms was assessed using a reference graded set of images from three screening centres in Scotland (1253 cases with observable/referable retinopathy and 6333 individuals with mild or no retinopathy). Screening outcomes and grading and diagnosis costs were modelled for a cohort of 180 000 people, with prevalence of referable retinopathy at 4%. Algorithm (b), which combines image quality assessment with detection algorithms for microaneurysms (MA), blot haemorrhages and exudates, was compared with a simpler algorithm (a) (using image quality assessment and MA/dot haemorrhage (DH) detection), and the current practice of manual grading. RESULTS: Compared with algorithm (a), algorithm (b) would identify an additional 113 cases of referable retinopathy for an incremental cost of pound 68 per additional case. Compared with manual grading, automated grading would be expected to identify between 54 and 123 fewer referable cases, for a grading cost saving between pound 3834 and pound 1727 per case missed. Extrapolation modelling over a 20-year time horizon suggests manual grading would cost between pound 25,676 and pound 267,115 per additional quality adjusted life year gained. CONCLUSIONS: Algorithm (b) is more cost-effective than the algorithm based on quality assessment and MA/DH detection. With respect to the value of introducing automated detection systems into screening programmes, automated grading operates within the recommended national standards in Scotland and is likely to be considered a cost-effective alternative to manual diseaseo disease grading.
机译:目的:评估与先前描述的算法相比,针对糖尿病性视网膜病变的改良自动分级算法的成本效益,并与人工分级进行比较。方法:使用来自苏格兰三个筛查中心的参考分级影像集(1253例可观察到/可观察到的视网膜病变病例和6333例轻或无视网膜病变的个体)评估了替代算法的有效性。对18万人的筛查结果,分级和诊断成本进行了建模,可称为视网膜病变的患病率为4%。算法(b)将图像质量评估与微动脉瘤(MA),印迹出血和渗出液的检测算法相结合,并与较简单的算法(a)(使用图像质量评估和MA /点出血(DH)检测)进行了比较,并且当前手动分级的做法。结果:与算法(a)相比,算法(b)将确定另外113例可参考的视网膜病变,每增加一例将增加68英镑的费用。与手动分级相比,自动分级将可减少54至123例可参考案例,每丢失一例可节省3834英镑至1727英镑的分级成本。在20年的时间范围内进行外推建模表明,每增加一个质量调整寿命年,人工分级将花费25,676英镑至267,115英镑之间。结论:(b)算法比基于质量评估和MA / DH检测的算法更具成本效益。关于将自动检测系统引入筛查计划的价值,自动分级在苏格兰的推荐国家标准范围内进行,可能被认为是人工疾病/无疾病分级的一种经济有效的替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号